glucaric acid has been researched along with Local Neoplasm Recurrence in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isomatsu, Y; Jinbo, S; Kaburagi, Y; Miki, M; Nashimo, T; Yamanaka, H | 1 |
Hayahara, N; Horii, A; Kashihara, N; Kawakita, J; Kishimoto, T; Maekawa, M; Morikawa, Y; Nishijima, T; Wada, S; Yasumoto, R | 1 |
2 other study(ies) available for glucaric acid and Local Neoplasm Recurrence
Article | Year |
---|---|
[Clinical study on prophylaxis of diacetyl-glucaro-(1-4) (6-3) dilactone for recurrence of bladder cancer].
Topics: Adult; Aged; Doxorubicin; Drug Therapy, Combination; Glucaric Acid; Humans; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Sugar Acids; Urinary Bladder Neoplasms | 1983 |
[Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Fluorouracil; Glucaric Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms | 1992 |